January 25, 2016
Researchers in OICR’s Informatics and Bio-computing and Genome Technologies Programs, together with their collaborators, have discovered a new sub-type of prostate cancer. The findings, published in the journal Nature Genetics, will assist scientists in creating better diagnostic tests and improve the personalized treatment of prostate cancer. The study was conducted as part of the Canadian Prostate Cancer Genome Network (CPC-GENE), a multidisciplinary team of researchers from across the country that is studying the genetic code of prostate cancer to better predict how patients will respond to treatment. CPC-GENE is part of the Canadian contribution to the International Cancer Genome Consortium.